Are patients undergoing intralesional collagenase <i>Clostridium histolyticum</i> injection therapy for Peyronie’s disease compliant? A 7-year analysis from a tertiary care men’s health center
Overall compliance rate for CCH injection therapy was 70.89%. Greater curvature reduction was demonstrated in compliant patients. Common reasons for incomplete treatment included adverse effects (15.1%), early satisfaction with results (14.1%), and unknown factors (45.4%). However, missing data and bias from retrospective design are major limitations.
Authors
- Elia Abou Chawareb (ORCID: https://orcid.org/0000-0002-0757-896X)
- Muhammed Hammad (ORCID: https://orcid.org/0000-0001-5396-1364)
- Supanut Lumbiganon (ORCID: https://orcid.org/0000-0001-9230-0075)
- Hana Nakamura
- Faysal A. Yafi (ORCID: https://orcid.org/0009-0004-9408-482X)
Institutions
- Khon Kaen University (TH)
- University of California, Irvine (US)
Publication Details
- Journal
- The Journal of Sexual Medicine
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1093/jsxmed/qdaf051
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00